Nasus Pharma Ltd Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Nasus Pharma Ltd (NSRX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$3.01 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2026-03-25
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|
| 2025-12-31 | -$3.01M 20-F · filed 2026-03-25 |